GKB OPHTHALMICS LTD. - 533212 - Shareholding for the Period Ended December 31, 2021
GKB Ophthalmics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here11-01-2022
11-01-2022
GKB OPHTHALMICS LTD. - 533212 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pooja BicholkarDesignation :- Company Secretary and Compliance Officer08-01-2022
GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2021. Kindly acknowledge receipt of the same.08-01-2022
GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations) , intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF), has purchased 5200 equity shares of the Company, aggregating to Rs. 4,53,634.95 , from 16.11.2021 to 31.12.2021, on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations. However, as a good Corporate Governance measure, the disclosure required under Regulation 7 (2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with copy of disclosure received from KrishnaGopal Gupta and Sons -HUF . Please acknowledge and take the same on record.03-01-2022
GKB OPHTHALMICS LTD. - 533212 - Clarification On Price Movement
We refer to your e-mail L/SURV/ONL/PV/VK/ 2021-2022 / 1014, dated December 17, 2021, seeking clarification, on significant movement in the share price of our Company, in the recent past. In order to enable the investors to make well informed investment decisions, the Company has been making to the Exchange, adequate and accurate disclosures of all material events, information, etc., from time to time, that have a bearing on operation / performance of the Company which includes all Price Sensitive Information as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has no pending announcements, that may have a bearing on price / volume behaviour of the Script that is pending disclosure, to the Stock Exchange, at this point of time. Hope we have clarified the matter. We request you to kindly take the same on record.17-12-2021
GKB OPHTHALMICS LTD. - 533212 - Clarification sought from GKB Ophthalmics Ltd
The Exchange has sought clarification from GKB Ophthalmics Ltd on December 17, 2021, with reference to Movement in Volume.The reply is awaited.17-12-2021
GKB OPHTHALMICS LTD. - 533212 - Disclosure Under Regulation 23(9) Of SEBI ( Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended September 30, 2021.
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find details of Related Party Transactions on consolidated basis for the half year ended September 30, 2021. Kindly take the information on record.08-12-2021
GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated November 13, 2021. Please acknowledge receipt.15-11-2021
GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On November 11, 2021, To Consider And Take On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2021
The meeting of the Board of Directors of the Company was held on November 11, 2021, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2021, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2021, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors'' Meeting started at 4:30 P.M. and ended at 5:50 P.M., on the same day. Kindly take the information on record.11-11-2021